Shure-Tech Investments - Limited Partnership engages primarily in investment activities with a focus on the insurance and finance technology sectors. Founded in 2000 and headquartered in Israel, the partnership invests in a diversified portfolio of technology-driven companies within finance and insurance industries, emphasizing innovation and technological advancement in these fields. Its investment scope includes financial technology startups and insurtech enterprises targeting improved financial services and insurance solutions. Recently, Shure-Tech Investments completed a $25 million funding round for Antidote Health Group, illustrating its strategic focus on high-potential investments. The partnership also entered a significant global distributor agreement with Huddly AS, a provider of AI-enhanced video conferencing technology, aligning with Shure's broader strategic alliance efforts to expand technology integrations and product offerings in collaboration and communication technologies within its portfolio. Operating primarily in Israel and extending strategic partnerships globally, Shure-Tech Investments continues to leverage its relationships to drive growth and capitalize on emerging technology trends in finance and insurance sectors. The firm is managed by CEO Ran Tzror and operates as a limited partnership listed under the ticker STEC.TA on the Tel Aviv Stock Exchange. Recent strategic moves include enhancing its investment focus on technology innovation and establishing partnerships to support the scaling of portfolio companies in the digital finance and insurtech markets. This positions Shure-Tech Investments as a key player in technology investments within its targeted verticals.